申请人:CARA THERAPEUTICS, INC.
公开号:US10913769B2
公开(公告)日:2021-02-09
The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure:
The compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions.
本发明涉及卡巴阿片受体的合成肽酰胺配体,特别是卡巴阿片受体的激动剂,这种激动剂表现出低 P450 CYP 抑制性和低脑穿透性。本发明的合成肽酰胺符合以下结构:
这些化合物可用于预防和治疗与多种疾病和病症相关的疼痛和炎症。